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High levels of plasma homocysteine are implicated in the pathogenesis of cardiovascular diseases especially if accompanied
by sleep apnea, but a direct pathogenetic link between plasma homocysteine levels and obstructive sleep apnea is debatable.
This association can have far-reaching public health implications considering the inverse association between folate and plasma
homocysteine. We used data from the 2005-2006 cycle of the National Health and Nutrition Examination Survey (NHANES)
to test the hypothesized associations. Of the 4490 subjects included in analysis, 177 reported sleep apnea. Age-standardized and
design-eﬀect-corrected prevalence rates were diﬀerential across gender, plasma homocysteine, and red cell folate status. Plasma
homocysteine was positively correlated with age (r = 0.38, P<0.0001). Multivariate analyses using sociodemographic and clinical
covariates demonstrated that plasma homocysteine levels retained their respective associations with self-reportedsleep apnea in all
models except when age was included as a covariate. Our results demonstrate that the claimed association of plasma homocysteine
with sleep apnea may be confounded by age.
1.Introduction
Obstructive sleep apnea (OSA)—a disorder in which a per-
son frequently stops breathing during sleep—results from an
obstruction of the upper airway that occurs because of inad-
equate motor tone of the tongue and/or airway dilator mus-
cles. In the United States, the prevalence of OSA is estimated
to be 3–7% in men and 2–5% in women [1]. In addition, up
to 93% of women and 82% of men may already have an
undiagnosed moderate to severe OSA [2]. Further, the co-
morbid occurrence of OSA with obesity is well-recognized:
prevalenceofOSAisreportedtobe41%amongpatientswith
a body mass index (BMI) greater than 28Kg/m2 and as high
as 78% in morbidly obese patients who present for bariatric
surgery [3, 4]. Of greater interest and importance, however,
is the association of OSA with cardiovascular disorders [5].
OSA has been identiﬁed as a crucial intermediate factor in
the pathophysiology of hypertension, ischemic heart disease,
arrhythmias, stroke and diabetes. It has been shown that
habitual snorers are at a 2 times higher likelihood of devel-
oping type 2 diabetes independently of other covariates [6].
Also, treatment of sleep-disordered breathing is known to
improve outcomes after congestive heart failure and stroke
[7, 8].
A possible mechanism for the strong correlation between
OSA and cardiovascular risk factors is the concomitant as-
sociation of plasma homocysteine levels with both these dis-
orders [9–11]. Homocysteine—a homologue of cysteine is a
biosynthesized amino acid in the metabolism of methionine.
Its production correlates with the deﬁciency of vitamins B6,
B12, and folic acid. Indeed, plasma homocysteine levels
are considered a good indicator of the deﬁciency of these2 Sleep Disorders
vitamins [12]. The importance of homocysteine metabolism
in the initiation or precipitation of cardiovascular diseases
can be appreciated by the fact that the attributable risk of
hyperhomocysteinemia in the epidemiology of cardiovascu-
lar diseases is nearly 25% and competes with that of other
well-known factors like smoking and hyperlipidemia [13]. In
contrast, the association of plasma homocysteine levels with
the risk, severity and long-term complications of OSA is less
clear. Over the last decade, 15 epidemiological studies [14–
28]haveexaminedthepotentialassociationofplasmahomo-
cysteine levels with OSA under varying scenarios (Table 1).
Ofthese,ninestudies[4–6,12,16,17,21,24,26]havereport-
ed overall or subgroup-speciﬁc association while six studies
[3, 8, 9, 13, 20, 23] have not found any association. Some
elegant reviews [9, 10] in this area have also not been fully
conclusive about such an association.
In concept, this association—if statistically and truly
existent–proﬀers an enticing opportunity for simple public
health measures like vitamin supplementation for the pre-
vention and control of OSA as well as its cardiovascular im-
plications [29]. However, as can be gleaned from Table 1,
most of the studies in this area have been based on relatively
small sample sizes which somewhat limits the public health
implication of these results. We therefore analyzed a large
nationally representative sample which was collected during
the National Health and Nutrition Examination Survey
(NHANES)inthe2005-2006cycle.Herewereporttheresults
of our investigation into the association of plasma homocys-
teine, and folate levels in the plasma as well as the red blood
cell (RBC) with the risk of self-reported sleep apnea in an
epidemiological context.
2. Methods
2.1. The NHANES 2005-2006 Dataset. The National Health
and Nutrition Examination Survey (NHANES) is an annual
survey conducted by the National Center of Health Statistics
(NCHS) of the Centers for Disease Control and Prevention
(CDC), Atlanta, Georgia, USA. It comprises a combination
of interviews, physical examination and laboratory tests to
assess the health and nutritional status of adults and children
in the United States. The NHANES 2005-2006 and 2007-
2008 cycles contain a questionnaire to identify subjects with
diagnosed sleep disorders. Preliminary results from this
questionnaire and the relationship of sleep apnea with obe-
sity in the 2005-2006 dataset have been described elsewhere
[30]. Even though both the 2005-2006 and 2007-2008 data-
sets contain data on the sleep questionnaire, currently the
plasma homocysteine levels are available for the 2005-2006
cycle only. Therefore, we included this dataset for our anal-
ysis. The NHANES 2005-2006 survey was approved by the
NCHS Ethics Review Board, and all participants or parents
(for minors) provided written consent. Total plasma homo-
cysteine levels were determined using the fully automated
ﬂuorescence polarization immunoassay (Abbott Laborato-
ries). The RBC and plasma folate estimations were conduct-
ed using the Quantaphase II folate/vitamin B12 radioas-
say (Bio-Rad Laboratories, Hercules, CA, USA) using 125I
and 57Co as tracers. Detailed description of the NHANES
2005-2006 survey can be found online at http://www.cdc
.gov/nchs/nhanes.htm.
2.2.OutcomesandPredictors. Ourprimaryoutcomeofinter-
est was presence of self-reported sleep apnea. Although the
association of plasma homocysteine has been predominantly
examined in the context of OSA, the NHANES sleep ques-
tionnairedidnotexplicitlyprobeintothetypeofsleepapnea.
Wethereforeusedthediagnosed,self-reportedsleepapneaas
ouroutcomeofinterest.Ourprimarypredictorswereplasma
homocysteine levels and RBC and plasma folate. However, as
described previously using this dataset, there were additional
variables that were (or could have been) associated with
altered risk of sleep apnea. These variables were age, gender,
race, country of birth, obesity, hypertension, ever smoking,
and ever alcohol use. We examined the potential association
of these sociodemographic and clinical variables with the
reported diagnosis of sleep apnea and included the signiﬁ-
cantvariablesassecondarycovariatesinmultivariatemodels.
For these analyses, we dichotomized plasma homocysteine,
RBC folate, and age based on the basis of the receiver oper-
ating characteristic (ROC) curves. The optimum cut-oﬀ
points for these variables were obtained at ≥8.02µmol/L,
≥279ng/mL, and ≥47 years, respectively. Education status
was dichotomized as high (high school or above) or low (up
to and including 11th grade), marital status as married or
other, obesity was deﬁned as BMI > 28Kg/m2,a n dh y p e r -
tension was deﬁned as an average (mean of three readings)
systolic blood pressure > 140mmHg and/or a diastolic blood
pressure > 90mmHg. Ever smoking was deﬁned as having
smoked at least 100 cigarettes in lifetime while ever alcohol
usewasdeﬁnedashavinghad12alcoholicdrinksinlifetime.
2.3. Statistical Analysis. Descriptive statistics included the
means and standard errors (for continuous variables) and
proportions (for discrete variables). Statistical signiﬁcance
for diﬀerence across study groups was assessed using the Stu-
dent’s t test (for continuous variables) or chi-square test (for
categorical variables). For binarizing continuous variables,
we made use of the ROC and selected the optimum cut-oﬀ
point by ﬁnding the shortest distance from the upper-left
corner of the ROC plot. The distance of a point on the
R O Cf r o mt h eu p p e rl e f tc o r n e rw a se s t i m a t e da sd = 
((1 −Sn)
2 +(1−Sp)
2), where Sn is the sensitivity and Sp
is the speciﬁcity of the binarized variable to predict self-re-
ported sleep apnea. We estimated two important eﬀect mea-
sures: age-standardized, design-eﬀect-corrected prevalence
rates of self-reported sleep apnea in various subgroups and
the design-eﬀect-adjusted multivariate association of the
above-mentioned predictors with the risk of self-reported
sleep apnea.
To determine the potentially independent association of
highplasmahomocysteinewithself-reportedsleepapnea,we
decomposed the observed total plasma homocysteine levels
into age-independent and age-dependent components using
the following approach. We ﬁtted a linear regression model
HCY = b∗ age + c, where HCY is the plasma homocysteine
level, b is the regression coeﬃcient, and c is constant. UsingSleep Disorders 3
Table 1: Summary of evidence for and against the association of plasma homocysteine with sleep apnea.
No. Authors [Ref] Year Type of study N Results
1 Chen et al. [17] 2011 Cross-sectional 102
Severity of OSA is associated with increased
homocysteine levels in subjects with ischemic
heart disease
2 Basoglu et al. [14] 2011 Case control 36 cases, 34 controls No association between plasma homocysteine
and OSA in obese patients
3 Cintra et al. [18] 2011 Matched case control 75 cases, 75 controls Cysteine but not homocysteine is diﬀerentially
distributed across OSA and non-OSA patients
4W a n g e t a l . [ 27] 2010 Cross-sectional 83 patients with OSA, 52
without OSA
Oxidative stress might induce high plasma
homocysteine levels in elderly patients with OSA
5C e r b o e t a l . [ 16] 2010 Case report 1 Early onset homocystinuria is associated with
apneic spells
6 Sariman et al. [25] 2010 Cross-sectional 38 cases of OSA Plasma homocysteine levels correlate with the
severity of OSA
7Y a v u z e t a l . [ 28] 2008 Cross-sectional 62 patients of OSA, 12
controls
Plasma homocysteine levels are elevated in
patients with OSA
8 Ozkan et al. [23] 2008 Cross-sectional 34 OSA patients, 15 controls Plasma homocysteine levels are raised in
patients with severe OSA
9R y a n e t a l . [ 24] 2007 Cross-sectional 80 patients with OSA, 30
controls
Plasma homocysteine levels are not associated
with either the risk or severity of OSA
10 Kumor et al. [21] 2006 Cross-sectional 47 patients of OSA, 12
controls
Plasma homocysteine levels are not diﬀerentially
distributed across patients and controls of OSA
11 Hachul de Campos
et al. [19] 2006 Cross-sectional 38 insomniac postmenopausal
women
Plasma homocysteine levels are not associated
with risk of apnea
12 Can et al. [15] 2006 Cross-sectional 30 OSA patients, 32 controls Serum homocysteine levels are signiﬁcantly
higher in OSA patients
13 Kokturk et al. [20] 2006 Cross-sectional 72 OSA patients, 42 controls Serum homocysteine is signiﬁcantly increased in
patients with OSA
14 Svatikova et al. [26] 2004 Case control 22 OSA patients, 20 controls
Plasma homocysteine levels exhibit diurnal
variation and are not diﬀerentially distributed
across patients and controls of OSA
15 Lavie et al. [22] 2001 Case control 237 cases of OSA, 108 controls Patients with ischemic heart disease and OSA
have elevated plasma homocysteine levels
the results of this model, we generated the two components
as HCYdep = b∗ age and HCYind = HCY − HCYdep,w h e r e
the suﬃxes dep and ind indicate the age-dependent and -
independent components, respectively. We then conducted
multivariate logistic regression analysis to examine the asso-
ciation of the HCYind and HCYdep components on the risk
of self-reported sleep apnea. For all analyses, we used the
svy commands contained in the Stata 12.0 statistical software
(Stata Corp, College Station, TX, USA). These commands
help account for the survey design eﬀect. The survey was a
single-stage, 30-cluster design, and we used the procedure
describedbytheCentersforDiseaseControltosetthesurvey
data in Stata. To calculate the prevalence rates, we used the
svy: mean command with the stdize option while, to con-
duct the multivariate analyses, we used the svy: estimate
command. Statistical signiﬁcance was evaluated at a type I
error rate of 0.05.
3. Results
3.1. Characteristics of Study Subjects. Plasma homocysteine
levels, RBC folate levels, sleep questionnaire responses, and
demographic information were available on 4490 subjects
in the NHANES 2005-2006 dataset of whom 177 (3.94%)
reported past diagnosis of sleep apnea. The distribution of
the sociodemographic and clinical variables in subjects with
and without reported sleep apnea is shown in Table 2.W e
found that the subjects with self-reported sleep apnea were
on an average over 8 years older than subjects who did not
report sleep apnea. Interestingly, the proportion of males,
non-Hispanic Whites, and subjects born in the US were ∼
18% higher than the respective proportions in subjects with
self-reported sleep apnea as compared to those without it.
Also, a higher proportion of subjects with self-reported ap-
nea were more educated and married. We also observed that
the persons with self-reported sleep apnea had a higher body
mass index, a higher percentage of ever smokers, and ever
alcohol users as compared to those without sleep apnea.
There was no signiﬁcant diﬀerence in the economic status of
the families as indicated by the poverty income ratio.
3.2. Prevalence of Self-Reported Sleep Apnea Based on Plasma
Homocysteine and RBC Folate Levels. We observed that the
mean plasma homocysteine and mean RBC folate levels were4 Sleep Disorders
Table 2: Sociodemographic, clinical, and relevant biochemical characteristics of the population included in this study (total n = 4490).
Characteristic Sleep apnea (n = 177) No sleep apnea (n = 4313) P
Age (yrs); mean(SD) 56.5 (15.2) 48.1 (19.0) <0.001
Males; n (%) 116 (65.5) 2036 (47.2) <0.001
Race/ethnicity; n (%) <0.001
Mexican American 11 (6.2) 899 (20.8)
Other Hispanic 2 (1.1) 136 (3.12)
Non-Hispanic White 120 (67.8) 2144 (49.7)
Non-Hispanic Black 40 (22.6) 962 (22.3)
Others 4 (2.3) 172 (4.0)
Country of birth; n (%) <0.001
United States 168 (94.9) 3345 (77.6)
Mexico 4 (2.3) 583 (13.5)
Elsewhere 5 (2.8) 385 (8.9)
Education; n (%) 0.039
Less than 9th grade 10 (5.7) 543 (12.6)
9–11th grade 20 (11.3) 670 (15.5)
High school 48 (27.1) 1018 (23.6)
Some college education 53 (29.9) 1228 (28.5)
College graduate 46 (26.0) 849 (19.7)
Refused/do not know 0 (0.0) 5 (0.1)
Marital status; n (%) 0.016
Married 121 (68.4) 2340 (54.3)
Widowed 11 (6.2) 388 (9.0)
Divorced 15 (8.5) 412 (9.6)
Separated 5 (2.8) 130 (3.0)
Never married 14 (7.9) 675 (15.7)
Living with partner 11 (6.2) 365 (8.5)
R e f u s e dt oa n s w e r 0( 0 . 0 ) 3( 0 . 1 )
Poverty income ratio; mean (SD) 2.84 (1.64) 2.68 (1.59) 0.194
Body mass index (Kg/m2); mean (SD) 34.90 (0.62) 28.55 (0.10) <0.001
Ever smoking; n (%) 101 (57.06) 2026 (46.97) 0.008
Ever alcohol use; n (%) 41 (23.16) 682 (15.81) 0.009
Plasma homocysteine (µmol/L); mean (SD) 9.49 (3.75) 8.44 (4.62) 0.003
RBC folate (ng/mL); mean (SD) 326.7 (180.4) 297.0 (135.4) 0.005
Plasma folate (ng/mL); mean (SD) 14.65 (15.4) 13.8 (9.5) 0.255
signiﬁcantly higher in subjects with self-reported sleep apnea
(Table 2), but the mean plasma folate levels were comparable
in subjects with or without self-reported sleep apnea. Yet, we
found that there was a negative correlation of the plasma
homocysteine levels with both the RBC and plasma folate
levels (r =− 0.08, P<0.0001 and r =− 0.03, P = 0.0321,
resp.).
Consideringtheseveralobservedassociationsofthesoci-
odemographic, clinical, and biochemical variables with self-
reported sleep apnea, we ﬁrst estimated the prevalence of
self-reported sleep apnea in various subgroups deﬁned by
these variables. We observed (Figure 1) that the overall age-
standardized prevalence rate of 4.3% was signiﬁcantly dif-
f e r e n t i a la c r o s sg e n d e r ;m a l e sh a dap r e v a l e n c er a t eo f∼6%
while females had a prevalence of ∼2.9%. Thus, we next
estimated age-standardized prevalence rates for other sub-
groups separately for males and females. Since we had ob-
served signiﬁcant diﬀerences in the mean plasma homocys-
teine and RBC folate (but not plasma folate) across self-
reported sleep apnea status, we ﬁrst categorized these two
variables into four groups based on the respective quartiles.
The quartiles were generated for all subjects irrespective of
the self-reported sleep apnea status. The quartiles for plasma
homocysteine were as follows: Q1, <6.23µmol/L; Q2, 6.23–
7.76µmol/L; Q3, 7.77–9.75µmol/L; Q4, >9.75µmol/L. The
q u a r t i l e sf o rR B Cf o l a t ew e r eQ 1 ,<207ng/mL; Q2, 207–
268ng/mL; Q3, 269–354ng/mL and Q4, ≥355ng/mL.
We observed that there was a consistent increase in the
age-standardizedprevalenceofself-reportedsleepapneaover
the four quartiles of plasma homocysteine levels in bothSleep Disorders 5
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Figure 1: Prevalence of diagnosed, self-reported sleep apnea in the NHANES 2005-2006 dataset based on gender and quartiles of plasma
homocysteine and RBC folate. The plot on the left is not standardized for age while the plot on the right shows age-standardized rates.
Prevalence rates are shown as horizontal bars, and the estimates are indicated by the value at the right side of the plots. Error bars indicate
the95%conﬁdence interval fortheprevalence rates. Prevalence ratesareshown forall subjects(red bars),females only(bluebars)and males
only(greenbars).RangeofvaluesforplasmahomocysteineandRBCfolaterepresentedbytheirrespectivequartilesisdescribedintext.HCY:
plasma homocysteine; RBF: RBC folate.
males and females albeit the prevalence rates were always
lower in females. However, a similar consistent trend was not
observed for the quartiles of RBC folate. With the exception
of the lowest quartile for RBC folate, the remaining three
quartiles demonstrated a consistent increase in the age-
standardized prevalence of self-reported sleep apnea. Again,
this trend was observed in males as well as females with con-
sistently lower rates in females.
We next estimated the age-standardized prevalence rates
for a combination of the plasma homocysteine and RBC fol-
ate quartiles (Figure 2). We found some interesting patterns
in these analyses. First, females with very low levels of plasma
homocysteine as well as RBC folate had a very high preva-
lence of self-reported sleep apnea. Second, low levels of both
plasma homocysteine and RBC folate were associated with
a very low prevalence of self-reported sleep apnea in males.
Third, highest prevalence of self-reported apnea in the males
was found in those who had high level of both plasma hom-
ocysteine and RBC folate. Fourth, the mechanistically ex-
pectedhighprevalenceofself-reportedapneainthelowRBC
folate/high plasma homocysteine subgroup was observed in
males only but not in females. Together these ﬁndings indi-
catedthatthereexistedacomplexandsurprisingcombinato-
rialassociationofplasmahomocysteineandRBCfolatelevels
with self-reported sleep apnea.
3.3. Multivariate Association of Plasma Homocysteine and
RBC Folate with Self-Reported Sleep Apnea. With the use of a
seriesof20nestedmultivariatelogisticregressionmodels,we
determined if inclusion of epidemiologically importantsig-
nificantcovariatesinﬂuencedtheassociationofplasmahom-
ocysteine and RBC folate with self-reported sleep apnea
(Figure 3). When no covariates were included along with the
two primary predictors, we found that both were independ-
ently associated with the risk of self-reported sleep apnea
(Model 1, Figure 3). The addition of other important vari-
ables like gender, non-Hispanic White race, birth in the
United States, education, marital status, obesity, ever smok-
ing, and ever alcohol use somewhat decreased the strength
of the associations of plasma homocysteine and RBC folate
with self-reported sleep apnea, however, in most instances,6 Sleep Disorders
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Figure 2: Age-standardized prevalence rates of diagnosed, self-reported sleep apnea based on combinations of quartiles of plasma homocys-
teine and RBC folate levels. Plots are for all subjects (a), females only (b), and males only (c). HCY: plasma homocysteine; RBF: RBC folate;
Q: quartile.
the associations retained their statistical signiﬁcance. Inter-
estingly however, when age was added to the multivariate
model (Models 10 and 18, Figure 3), the signiﬁcance of both
plasma homocysteine and RBC folate reduced drastically.
The results of the full model (Model 18 in Figure 3)a r e
shown in detail in Table 3.
It is noteworthy that high BMI, male gender, age > 46
years, alcohol use, high education, and married status con-
tinued to demonstrate independent association with self-re-
ported sleep apnea in a multivariate context, but the asso-
ciation of high plasma homocysteine and high RBC folate
became statistically insigniﬁcant (Table 3). Indeed, all the
multivariate models (Models 18, 19, 20) that contained age
as a covariate demonstrated a nonsigniﬁcant association of
plasma homocysteine and folate with self-reported sleep
apnea. Since the information of hypertension and cardio-
vascular disease was not available on large number of study
subjects, we added these variables to the full model (Model
18) and observed that the strength as well as signiﬁcance of
the association of plasma homocysteine and RBC folate with
self-reported sleep apnea was further diminished (Models 19
and 20).
Table 3: Results from the full multivariate logistic regression
analysis (Model 18 in Figure 3) for the outcome of self-reported
sleep apnea.
Covariate OR 95% CI P
High plasma homocysteine 1.24 0.85–1.83 0.244
High RBC folate 1.26 0.84–1.89 0.252
Male gender 2.22 1.45–3.4 0.001
Non-Hispanic White race 1.21 0.74–1.96 0.420
Birth in the United States 1.89 0.93–3.82 0.073
BMI > 28Kg/m2 7.56 4.14–13.79 <0.001
High education 1.71 1.21–2.41 0.005
Married 1.60 1.07–2.39 0.025
Ever smoker 1.28 0.76–2.14 0.334
Ever alcohol use 2.01 1.3–3.11 0.004
Age > 46 years 2.19 1.39–3.44 0.002
OR: odds ratio; CI: conﬁdence interval; P: signiﬁcance value.
Theresultspresentedthusfarindicatedastrongpotential
inﬂuence of age on the association of plasma homocysteineSleep Disorders 7
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Figure 3: Multivariate association of high plasma homocysteine and RBC folate levels with the risk of self-reported sleep apnea. Results are
shown as point (diamonds) and 95% conﬁdence intervals (error bars) for odds ratios estimated through a series of nested logistic regression
commands. Twenty logistic regression models (indicated by # on the left) were run with varying combinations of covariates. The covariates
included were G: male gender; R: non-Hispanic white race; U: birth in the United States; B: body mass index > 28Kg/m2; E: high education;
M :m a r r i e d ;S :e v e rs m o k e r ;a :e v e ra l c o h o lu s e ;A :a g e> 46 years; H: hypertension; C: cardiovascular disease. Model 1 contained only high
plasmahomocysteineandhighRBCfolateastheindependentvariables.Theresultsfrommodels19and20cannotbedirectlycomparedwith
the remaining 18 models since the information for hypertension and cardiovascular disease was not available for a large number of subjects
(shown under column titled N). Statistically signiﬁcant associations (when the error bars did not straddle unity indicated by dashed vertical
lines) are shown in red color for high plasma homocysteine and in blue color for high RBC folate. Statistically nonsigniﬁcant associations
are shown in black color for plasma homocysteine and gray color for RBC folate. Statistical signiﬁcance is shown on individual plots as
color-coded P values.
with self-reported sleep apnea. Considering the disposition
of the survey data that we analyzed, we further reﬁned our
analyses. We examined if the strong positive correlation of
age with plasma homocysteine levels (r = 0.38, P<0.0001)
masked the potentially true, independent association of plas-
ma homocysteine with self-reported sleep apnea. We found
that the odds ratio associated with a unit increase in the
HCYdep levels was 1.51 (95% conﬁdence interval 1.36–1.68),
P<0.0001 while that for a unit increase in HCYind was 1.02
(95% conﬁdence interval 0.99–1.05), P = 0.189. These re-
sults demonstrated that the observed overall association of
the plasma homocysteine levels with the risk of self-reported
sleep apnea was indeed due to age.
4. Discussion
In this large, nationally representative sample of noninsti-
tutionalized US subjects, we observed that plasma homo-
cysteine is not independently associated with an altered risk
of self-reported sleep apnea. Further, we found that age was
the most important confounding factor that could have con-
tributed to an apparent association of plasma homocysteine
with the risk of self-reported sleep apnea. It has been shown
by other investigators in diﬀering contexts [31–34] that plas-
ma homocysteine levels increase with age. It is also very well
recognized that the risk of cardiovascular morbidity rises
with age as well as plasma homocysteine levels. However, this
concomitant elevation of homocysteine with age appears to
beassociativeratherthancausalinthecontextofsleepapnea.
As identiﬁed by Lavie et al. [22], Svatikova et al. [26]a n d
Winnicki and Palatini [9] sleep apnea and high plasma hom-
ocysteine levels can independently and additively increase
the risk of subsequent cardiovascular morbidity; however,
a potentially causal link between elevated plasma homocys-
teine and sleep apnea does not seem to be operative from our
results.
Interestingly and intriguingly, we observed a positive as-
sociation of the RBC folate levels with the risk of self-report-
ed sleep apnea in spite of a mild negative correlation between8 Sleep Disorders
RBC folate and plasma homocysteine levels. Further, despite
a strong positive correlation between plasma and RBC folate
(r = 0.49, P<0.0001; data not shown), we observed that
plasma folate levels were not associated with an altered risk
of self-reported sleep apnea. These observations have two
important implications. First, these ﬁndings indicate that
initial enthusiasm generated by the possibility of vitamin
supplementation aimed at reducing the prevalence of sleep
apnea may be an oversimpliﬁcation of the apnea challenge.
For example, even though folate fortiﬁcation of grains has
been attributed with a decrease in homocysteine levels as
wellascardiovascularmorbidity[35],suchadecreasehasnot
been observed in the prevalence of sleep apnea in the United
States. Second, the National Pathology Alliance benchmark-
ing guidelines [36] stipulate that RBC and plasma folate can
actassurrogatesofeachotherandthatnoadditionalinsights
are gained by screening samples by both these methods.
However, our results demonstrate that these methods may
not be redundant and that diﬀerential insights can be ob-
tained by a careful examination of the results. Thus, the issue
deserves a closer investigation.
Although recruiting a large, representative sample, the
current study was an observational study, and, therefore, all
limitations implicit in such study designs and compounded
by the survey sample selection should be considered while
interpreting these results. In addition, it should be noted that
the NHANES survey methodology did not use established
apnea screening questionnaires but rather recorded self-re-
ported sleep apnea. Therefore, there exist possibilities of
missed diagnoses and a consequent misclassiﬁcation bias.
Despite these limitations, our results indicate that increased
plasma homocysteine levels, augmented cardiovascular mor-
bidity, and enhanced risk and prevalence of self-reported
sleep apnea may actually be representing a syndromic con-
stellation of the aging phenomenon. Consequently, more in-
volvedandintenseeﬀortstounderstandthegeneticandenvi-
ronmental contribution and interaction need to be under-
taken before a mechanistic understanding, and the public
health implications thereof can be fully realized.
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